Back
Stereotaxis, Inc. Vs. Charles River Laboratories International, Inc. Industry Stock Comparison
Sell
38
STXS
Stereotaxis, Inc.
Last Price:
$2.31
Seasonality Move:
2.35%
Buy
52
CRL
Charles River Laboratories International, Inc.
Last Price:
$202.53
Seasonality Move:
6.32%
Sell
38
Stereotaxis, Inc. (STXS)
is a Sell
Is Stereotaxis, Inc. a Buy, Sell or Hold?
-
The current Stereotaxis, Inc. [STXS] share price is $2.30. The Score for STXS is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
-
STXS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
52
Charles River Laboratories International, Inc. (CRL)
is a Buy
Is Charles River Laboratories International, Inc. a Buy, Sell or Hold?
-
The current Charles River Laboratories International, Inc. [CRL] share price is $199.48. The Score for CRL is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
-
CRL is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
STXS Stock Price Chart
What is Stereotaxis, Inc.'s stock price today?
-
The Stereotaxis, Inc. share price today is $2.30Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and STXS is experiencing buying pressure, which is a positive indicator for future bullish movement.
CRL Stock Price Chart
What is Charles River Laboratories International, Inc.'s stock price today?
-
The Charles River Laboratories International, Inc. share price today is $199.48Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CRL is experiencing selling pressure, which indicates risk of future bearish movement.
STXS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.64 | Buy |
| Relative Strength Index (14 RSI): | 42.45 | Sell |
| Chaikin Money Flow: | 218041 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.32 - 2.44) | Sell |
| Bollinger Bands (100): | (2.41 - 3.03) | Sell |
CRL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 6.49 | Buy |
| Relative Strength Index (14 RSI): | 62.48 | Buy |
| Chaikin Money Flow: | -305944 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (182.24 - 201.12) | Buy |
| Bollinger Bands (100): | (156.47 - 188.21) | Buy |
STXS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.38 | Sell |
| 20-day SMA: | 2.37 | Sell |
| 50-day SMA: | 2.52 | Sell |
| 200-day SMA: | 2.41 | Sell |
| 8-day EMA: | 2.16 | Buy |
| 20-day EMA: | 1.49 | Buy |
| 50-day EMA: | 0.78 | Buy |
| 200-day EMA: | 0.23 | Buy |
CRL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 201.8 | Sell |
| 20-day SMA: | 195.3 | Buy |
| 50-day SMA: | 183.58 | Buy |
| 200-day SMA: | 158.47 | Buy |
| 8-day EMA: | 200.55 | Sell |
| 20-day EMA: | 194.92 | Buy |
| 50-day EMA: | 183.02 | Buy |
| 200-day EMA: | 115.98 | Buy |
Stereotaxis, Inc. Earnings Growth & STXS Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.07 per share, and an increase next year of $0.15 per share.
Charles River Laboratories International, Inc. Earnings Growth & CRL Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.43 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.70 per share, and an increase next year of $0.99 per share.
Stereotaxis, Inc. Technical Analysis
| Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 17 | 18 | 19 | 22 | 23 | 24 | 26 | 29 | 30 | 31 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Charles River Laboratories International, Inc. Technical Analysis
| Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 17 | 18 | 19 | 22 | 23 | 24 | 26 | 29 | 30 | 31 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||